TT
NVO

TI-Trust’s Novo Nordisk NVO Stock Holding History

TI-Trust’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$5K Buy
+162
New +$4.49K ﹤0.01% 307

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $7.77B AUM 9.43% 1-Year Est. Return

TI-Trust's NVO Position: Q4 2019 in Review

TI-Trust opened a new position in Novo Nordisk (NVO) in Q4 2019: 162 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #307 among its holdings.

640 funds tracked by Wall St. Rank hold NVO as of Q4 2019.

  • TI-Trust held 162 shares of Novo Nordisk worth $5K as of Q4 2019.
  • Novo Nordisk was a new TI-Trust position in Q4 2019.
  • Novo Nordisk made up ﹤0.01% of TI-Trust's portfolio in Q4 2019, its #307 holding.
  • 640 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2019.

Based on TI-Trust's 13F filing for Q4 2019, filed 7 Feb 2020.